# A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting

> **NCT00418678** · PHASE4 · TERMINATED · sponsor: **Veeda Oncology** · enrollment: 16 (actual)

## Conditions studied

- Nausea and Vomiting

## Interventions

- **DRUG:** Cesamet

## Key facts

- **NCT ID:** NCT00418678
- **Lead sponsor:** Veeda Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-08
- **Primary completion:** 2007-12
- **Final completion:** 2007-12
- **Target enrollment:** 16 (ACTUAL)
- **Why stopped:** Enrollment was too slow
- **Last updated:** 2010-12-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418678, "A Phase IV Trial of Cesamet™ Given With Standard Antiemetic Therapy for Chemotherapy-induced Nausea and Vomiting". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00418678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*